ErbB-3-pGL3 Citations (4)
Originally described in: Dominant negative interference of transcription factor AP-2 causes inhibition of ErbB-3 expression and suppresses malignant cell growth.Zhu CH, Domann FE Breast Cancer Res Treat. 2002 Jan;71(1):47-57. PubMed
Articles Citing ErbB-3-pGL3
| Articles |
|---|
A genetic cell context-dependent role for ZEB1 in lung cancer.
Zhang T, Guo L, Creighton CJ, Lu Q, Gibbons DL, Yi ES, Deng B, Molina JR, Sun Z, Yang P, Yang Y.
Nat Commun. 2016 Jul 26;7:12231. doi: 10.1038/ncomms12231.
PubMed
Associated Plasmids |
| Macroautophagy Regulates Nuclear NOTCH1 Activity Through Multiple p62 Binding Sites. Zhang T, Guo L, Wang Y, Yang Y. IUBMB Life. 2018 Oct;70(10):985-994. doi: 10.1002/iub.1891. Epub 2018 Sep 12. PubMed |
| EGFR Inhibition Enhances the Cellular Uptake and Antitumor-Activity of the HER3 Antibody-Drug Conjugate HER3-DXd. Haikala HM, Lopez T, Kohler J, Eser PO, Xu M, Zeng Q, Teceno TJ, Ngo K, Zhao Y, Ivanova EV, Bertram AA, Leeper BA, Chambers ES, Adeni AE, Taus LJ, Kuraguchi M, Kirschmeier PT, Yu C, Shiose Y, Kamai Y, Qiu Y, Paweletz CP, Gokhale PC, Janne PA. Cancer Res. 2022 Jan 1;82(1):130-141. doi: 10.1158/0008-5472.CAN-21-2426. Epub 2021 Sep 21. PubMed |
| ARAF suppresses ERBB3 expression and metastasis in a subset of lung cancers. Mooz J, Riegel K, Ps H, Sadanandam A, Marini F, Klein M, Werner U, Roth W, Wilken-Schmitz A, Tegeder I, Rajalingam K. Sci Adv. 2022 Mar 18;8(11):eabk1538. doi: 10.1126/sciadv.abk1538. Epub 2022 Mar 18. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.